sales@businessmarketinsights.com     UK: +442081254005
   

Middle East & AfricaDrug Modelling Software Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Type (Database, Software, and Others); and Application (Drug Discovery and Development, Computational Physiological Medicine, Disease Modelling, Medical Imaging, Predictive Analysis of Drug Targets, Simulation Software, Cellular Simulation, and Others) and Country

Code: TIPRE00015159 | Pages: 109 | Industry: Healthcare IT | Date: Oct 2020
Covid

Market Introduction

Drug modelling has become an essential tool in the drug design process. Software based drug discovery and development methods are playing key role in the development of novel drugs. Software based methods such as molecular modelling, structure-based drug design, structure-based virtual screening, ligand interaction and molecular dynamics are considered to be powerful tool for investigation of pharmacokinetic and pharmacodynamic properties of drugs. These methods are fast, accurate, and provide valuable insights of experimental findings and mechanisms of action. In addition, appropriate implementation of these techniques may help in reducing cost of drug designing and development.

Market Overview and Dynamics

The Middle East & Africadrug modelling softwaremarket is expected to reach US$ 487.02 million by 2027 from US$ 297.94 million in 2019. The market is anticipated to grow at a CAGR of 6.6% during 2019–2027.The increasing adoption of in-silico modelling tools in drug discovery, and increasing economic burden of drug discovery are the major factors expected to boost the growth of the drug modelling software market in Middle East & Africa. However, the market is likely to get impacted by the risk factor such as less adoption in emerging countries during the forecast period.

Key Market Segments

In terms of product type, the softwaresegment accounted for the largest share of the Middle East & Africadrug modelling software market in 2019. In terms of application, drug discovery and developmentsegment accounted for the largest share of the Middle East & Africadrug modelling software market in 2019.

Major Sources and Companies Listed

Several major primary and secondary sources associated with the Middle East & Africadrug modelling softwaremarket report are theCOVID-19 Command and Control Centre (CCC),World Health Organization (WHO),and others.

Reasons to buy report

  • It provides understanding of the Middle East & Africa, drug modelling software market landscape and identifies drug modelling software market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East & Africadrug modelling software market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the drug modelling softwaremarket by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis ofdrug modelling software market performance of various segments pertaining to the Middle East & Africadrug modelling software market.
  • It providesdrug modelling software market revenue forecast of the market based on various segments for the period from 2019 to 2027.

MIDDLE EAST & AFRICADRUG MODELLING SOFTWAREMARKET SEGMENTATION

By ProductType

  • Database
  • Software
  • Others

 

By Application

  • Drug Discovery and Development
  • Computational Physiological Medicine
  • Disease Modelling
  • Medical Imaging
  • Predictive Analysis of Drug Targets
  • Simulation Software
  • Cellular Simulation
  • Others

 

By Country

  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa

 

Company Profiles

  • Crown Bioscience Inc (JSR life science)
  • Compugen Ltd.
  • Biognos AB
  • Dassault Systèmes
  • Acellera

 

 

 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Middle East & Africa Drug Modelling Software Market – By Product Type

1.3.2        Middle East & Africa Drug Modelling Software Market – By Application

1.3.3        Middle East & Africa Drug Modelling Software Market – By Country

2.           Middle East & Africa Drug Modelling Software Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Middle East & Africa Drug Modelling Software Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1        Drug Modelling Software Market - Middle East & Africa PEST Analysis

4.3         Expert Opinion

5.           Middle East & Africa Drug Modelling Software Market - Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Increasing Adoption of Modelling Tools in Drug Discovery

5.1.2        Increasing Economic Burden of Drug Discovery

5.2         Key Market Restraints

5.2.1        Less Adoption in Emerging Countries

5.3         Key Market Opportunities

5.3.1        Strategic Activities by Market Players

5.4         Future Trends

5.4.1        Growing Adoption of Artificial Intelligence in Drug Discovery

5.5         Impact analysis

6.           Drug Modelling Software Market – Middle East & Africa Analysis

6.1         Middle East & Africa Drug Modelling Software Market Revenue Forecasts and Analysis

7.           Middle East & Africa Drug Modelling Software Market Analysis and Forecasts To 2027 – By Product Type

7.1         Overview

7.2         Middle East & Africa Drug Modelling Software Market, By Product Type 2019 & 2027 (%)

7.2.1        Middle East & Africa Drug Modelling Software Market Revenue and Forecasts to 2027, By Product Type (US$ Mn)

7.3         Database

7.3.1        Overview

7.3.2        Middle East & Africa Database Market Revenue and Forecast to 2027 (US$ Mn)

7.4         Software

7.4.1        Overview

7.4.1.1          Middle East & Africa Software Revenue and Forecasts to 2027 (US$ Mn)

7.5         Other Product Types

7.5.1        Overview

7.5.2        Middle East & Africa Other Product Types Market Revenue and Forecast to 2027 (US$ Mn)

8.           Middle East & Africa Drug Modelling Software Market Analysis and Forecasts To 2027 – By Application

8.1         Overview

8.2         Middle East & Africa Drug Modelling Software Market, By Application 2019 & 2027 (%)

8.2.1        Middle East & Africa Drug Modelling Software Market Revenue and Forecasts to 2027, By Application (US$ Mn)

8.3         Drug Discovery and Development

8.3.1        Overview

8.3.2        Middle East & Africa Drug Discovery and Development Market Revenue and Forecast to 2027 (US$ Mn)

8.4         Computational Physiological Medicine

8.4.1        Overview

8.4.2        Middle East & Africa Computational Physiological Medicine Market Revenue and Forecasts to 2027 (US$ Mn)

8.5         Disease Modelling

8.5.1        Overview

8.5.2        Middle East & Africa Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

8.6         Medical Imaging

8.6.1        Overview

8.6.2        Middle East & Africa Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

8.7         Predictive Analysis of Drug Targets

8.7.1        Overview

8.7.2        Middle East & Africa Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

8.8         Simulation Software

8.8.1        Overview

8.8.2        Middle East & Africa Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

8.9         Cellular Simulation

8.9.1        Overview

8.9.2        Middle East & Africa Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

8.10      Others

8.10.1     Overview

8.10.2     Middle East & Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

9.           Drug Modelling Software Market Revenue and Forecasts To 2027 – Geographical Analysis

9.1         Middle East & Africa Drug modelling software Market Revenue and Forecasts To 2027

9.1.1        Overview

9.1.2        Middle East & Africa: Drug Modelling Software Market - Revenue and Forecast to 2027 (US$ Million)

9.1.3        Middle East & Africa Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

9.1.4        Middle East & Africa Drug Modelling Software Market, by Application– Revenue and Forecast to 2027  (USD Million)

9.1.5        Middle East & Africa: Drug Modelling Software Market, by Country, 2018 & 2027 (%)

9.1.6        Saudi Arabia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.1          Saudi Arabia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.6.2          Saudi Arabia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.6.3          Saudi Arabia Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

9.1.7        UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

9.1.7.3          UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

9.1.8        South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          South Africa Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

9.1.8.3          South Africa Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

10.        Impact of COVID-19 Pandemic on Middle East & Africa Drug Modelling Software Market

10.1      Middle East & Africa: Impact Assessment of COVID-19 Pandemic

11.        Company Profiles

11.1      Compugen Ltd.

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      Biognos AB

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      Dassault Systèmes

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Acellera

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.5      Crown Bioscience Inc (JSR life science)

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

12.        Appendix

12.1      About the Insight Partners

12.2      Glossary of Terms

LIST OF TABLES

Table 1.             Middle East & Africa Drug Modelling Software Market Revenue and Forecasts To 2027, By Product Type (US$ Mn)

Table 2.             Middle East & Africa Drug Modelling Software Market Revenue and Forecasts To 2027, By Application (US$ Mn)

Table 3.             Middle East & Africa Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

Table 4.             Middle East & Africa Drug Modelling Software Market, by Application– Revenue and Forecast to 2027 (USD Million)

Table 5.             Saudi Arabia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Saudi Arabia Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 7.             UAE Drug Modelling Software Market, by Product Type– Revenue and Forecast to 2027 (USD Million)

Table 8.             UAE Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 9.             South Africa Drug Modelling Software Market, by Product Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          South Africa Drug Modelling Software Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 11.          Glossary of Terms, Drug Modelling Software Market

LIST OF FIGURES

Figure 1.           Drug Modelling Software Market Segmentation

Figure 2.           Middle East & Africa Drug Modelling Software Market Overview

Figure 3.           Software Segment Held Largest Share of Drug Modelling Software Market

Figure 4.           Saudi Arabia is Expected to Show Remarkable Growth During the Forecast Period

Figure 5.           Middle East & Africa Drug Modelling Software Market - Leading Country Markets (US$ Mn)

Figure 6.           Drug Modelling Software Market - Middle East & Africa PEST Analysis

Figure 7.           Drug Modelling Software Market Impact Analysis of Driver and Restraints

Figure 8.           Middle East & Africa Drug Modelling Software Market – Revenue Forecasts and Analysis – 2019- 2027

Figure 9.           Middle East & Africa Drug Modelling Software Market, By Product Type 2019 & 2027 (%)

Figure 10.        Middle East & Africa Database Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 11.        Middle East & Africa Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 12.        Middle East & Africa Other Product Types Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 13.        Middle East & Africa Drug Modelling Software Market, By Application 2019 & 2027 (%)

Figure 14.        Middle East & Africa Drug Discovery and Development Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 15.        Middle East & Africa Computational Physiological Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 16.        Middle East & Africa Disease Modelling Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 17.        Middle East & Africa Medical Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 18.        Middle East & Africa Predictive Analysis of Drug Targets Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 19.        Middle East & Africa Simulation Software Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.        Middle East & Africa Cellular Simulation Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.        Middle East & Africa Others Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.        Middle East & Africa: Drug Modelling Software Market, by Key Country – Revenue (2019) (USD Million)

Figure 23.        Middle East & Africa Drug Modelling Software Market Revenue and Forecast to 2027 (USD Million)

Figure 24.        Middle East & Africa: Drug Modelling Software Market, by Country, 2018 & 2027 (%)

Figure 25.        Saudi Arabia: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.        UAE: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.        South Africa: Drug Modelling Software Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.        Impact of COVID-19 Pandemic in Middle East & Africa Country Markets

  1. Crown Bioscience Inc (JSR life science)
  2. Compugen Ltd.
  3. Biognos AB
  4. Dassault Systèmes
  5. Acellera
  • It provides understanding of the Middle East & Africa, drug modelling software market landscape and identifies drug modelling software market segments that are most likely to guarantee a strong return.
  • It guides stay ahead of the race by comprehending the ever-changing competitive landscape for the Middle East & Africadrug modelling software market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the drug modelling softwaremarket by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis ofdrug modelling software market performance of various segments pertaining to the Middle East & Africadrug modelling software market.
  • It providesdrug modelling software market revenue forecast of the market based on various segments for the period from 2019 to 2027.

Related Tags

Purchase Options
Single User License
$3000
Site License
$4000
Enterprise License
$5000